- Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethy…
Number of the records: 1  

Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection

  1. LIU, Z. J. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection. In Neoplasma. ISSN 0028-2685. Bratislava : AEPress, 2017, 2017, vol. 64, no. 5, s. 795-802.
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.